Biogen
BIIB
#859
Rank
โ‚น1.945 T
Marketcap
โ‚น13,348
Share price
1.29%
Change (1 day)
-30.22%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น1.009 Trillion

According to Biogen's latest financial reports the company's total liabilities are โ‚น1.009 Trillion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Biogen - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น1.002 T8.53%
2022-12-31โ‚น923.96 B-3.9%
2021-12-31โ‚น961.47 B-5.64%
2020-12-31โ‚น1.018 T2.83%
2019-12-31โ‚น990.88 B15.61%
2018-12-31โ‚น857.06 B21.42%
2017-12-31โ‚น705.83 B-3.36%
2016-12-31โ‚น730.39 B8.5%
2015-12-31โ‚น673.18 B203.42%
2014-12-31โ‚น221.86 B10.76%
2013-12-31โ‚น200.32 B15.55%
2012-12-31โ‚น173.36 B24.96%
2011-12-31โ‚น138.73 B17.14%
2010-12-31โ‚น118.43 B11.46%
2009-12-31โ‚น106.25 B-16.42%
2008-12-31โ‚น127.13 B4.68%
2007-12-31โ‚น121.44 B95.44%
2006-12-31โ‚น62.14 B-6.43%
2005-12-31โ‚น66.41 B-34.45%
2004-12-31โ‚น101.31 B-9.2%
2003-12-31โ‚น111.57 B144.92%
2002-12-31โ‚น45.55 B153.66%
2001-12-31โ‚น17.95 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น7.041 T 597.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.988 T 195.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.602 T 1,048.97%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.721 T 961.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น9.134 T 804.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น22.58 B-97.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.139 T 408.97%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น263.19 B-73.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น328.52 B-67.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น184.10 B-81.77%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands